Vasopressin and its analogues in the therapy of shock;Vazopresin a jeho analoga v léčbé šokový ch stavů

Casopis Lekaru Ceskych

Volumn 143, Issue 5, 2004, Pages 307-312

  Novák, František ^a,b   Lubanda, H ^a   Onderkova R ^a   Zak A ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Nitric oxide; Sepsis; Shock; Terlipressin; Therapy; Vasopressin

Indexed keywords

ADRENALIN; ARGIPRESSIN; CALCIUM ION; CORTICOTROPIN; DESMOPRESSIN; DOBUTAMINE; DOPAMINE; DOPEXAMINE; ISOPRENALINE; LYPRESSIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORADRENALIN; ORNIPRESSIN; OXYTOCIN; TERLIPRESSIN; VASOPRESSIN; VASOPRESSIN DERIVATIVE; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V2 RECEPTOR; VASOPRESSIN V3 RECEPTOR;

BLOOD VESSEL TONE; CARDIOVASCULAR AUTOREGULATION; DRUG CHOICE; DRUG EFFICACY; DRUG INDICATION; HORMONAL THERAPY; HUMAN; PATHOPHYSIOLOGY; REVIEW; SHOCK; SIDE EFFECT;

ANIMALS; HUMANS; LYSINE VASOPRESSIN; SHOCK; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS; VASODILATION; VASOPRESSINS;

EID: 2642565123     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Landry, D. W., Oliver, J. A.: The pathogenesis of vasodilatory shock. N. Engl. J. Med., 2001, 345, s. 588-595.
2. Vincent, J. L.: Hemodynamic support in septic shock. Intensive Care Med., 2001, 27 (Suppl. 1), s. S80-S92.
3. Wenzel, V., Lindner, K. H.: Employing vasopressin during cardiopulmonary resuscitation and vasodilatory shock as a lifesaving vasopressor. Cardiovasc. Res., 2001, 51, s. 529-541.
4. Holmes, C. L., Patel, B. M., Russell, J. A., Walley, K. R.: Physiology of vasopressin relevant to management of septic shock. Chest, 2001, 120, s. 989-1002.
5. Robin, J. K., Oliver, J. A., Landry, D. W.: Vasopressin deficiency in the syndrome of irreversible shock. J Trauma, 2003, 54 (Suppl. 5), s. S149-S154.
6. Birnbaumer, M.: Vasopressin receptors. Trends Endocrinol. Metab, 2000, 11, s. 406-410.
7. Dunser, M. W., Mayr, A. J., Ulmer, H. et al.: Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation, 2003, 107, s. 2313-2319.
8. Sharshar, T., Blanchard, A., Paillard, M. et al.: Circulating vasopressin levels in septic shock. Crit. Care Med., 2003, 31, s. 1752-1758.
9. Argenziano, M., Choudhri, A. F., Oz, M.: A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device palecement. Circulation, 1997, 96 (Suppl. 2), s. 286-290.
10. Argenziano, M., Chen, J. M., Choudhri, A. F. et al.: Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac. Cardiovasc. Surg., 1998, 116, s. 973-980.
11. Argenziano, M., Chen, J. M., Cullinane, S.: Arginine vasopressin in the managenent of vasodilatory shock after cardiac transplantation. Heart Lung Transplant., 1999, 18, s. 814-817.
12. Bracco, D., Chiolero, R. L., Revelly, J. P.: Systemic and splanchnic haemodynamic effects of vasopressin in the treatment od vasodilatory shock after left ventricular assist device placement. Intensive Care Med., 2001, 27 (Suppl. 2), s. A15.
13. Chen, J. M., Cullinane, S., Sapanier, T. B. et al.: Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation, 1999, 100, s. 244-246.
14. De Kock, M., Laterre, P. F., Andruetto, P. et al.: Ornipressin (Por 8): An efficient alternative to counteract hypotension during combined general/epidural anesthesia. Anesth. Analg., 2000, 90, s. 1301-1307.
15. Dunser, M. W., Mayr, A. J., Ulmer, H. et al.: The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth. Analg., 2001, 93, s. 7-13.
16. Dunser, M. W., Mayr, A. J., Stallinger,A. et al.: Cardiac performance during vasopressin infusion in postcardiotomy shock. Intensive Care Med., 2002, 28, s. 746-751.
17. Eyraud, D., Brabant, S., Nathalie, D. et al.: Treatment of intraoperative refractory hypotension with terlipressin in patients chronically treated with an antagonist of the renin-angiotensin system. Anesth. Analg., 1999, 88, s. 980-984.
18. Gold, J. A., Cullinane, S., Chen, J. et al.: Vasopressin as an alternative to norepinephrine in the treatment of milrinone-induced hypotension. Crit. Care Med., 2000, 28, s. 249-252.
19. Holmes, C. L., Walley, K. R., Chittock, D. R. et al.: The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med., 2001, 27, s. 1416-1421.
20. Iwai, A., Sakano, T., Uenishi, M. et al.: Effects of vasopressin and catecholamines on the maintenance of circulatory stability in brain-dead patients. Transplantation, 1989, 48, s. 613-617.
21. Katz, K., Lawler, J., Wax, J. et al.: Vasopressin pressor effects in critically ill children during evaluation for brain death and organ recovery. Resuscitation, 2000, 47, s. 33-40.
22. Kochar, M. S.: Hemodynamic effects of lysine-vasopressin in orthostatic hypotension. Am. J. Kidney Dis., 1985, 6, s. 49-52.
23. Landry, D. W., Levin, H. R., Gallant, E. M. et al.: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation, 1997, 95, s. 1122-1125.
24. Landry, D. W., Levin, H. R., Gallant, E. M. et al.: Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit. Care Med., 1997, 25, s. 1279-1282.
25. Lindberg, J. S., Copley, J. B., Melton, K. et al.: Lysine vasopressin in the treatment of refractory hemodialysis-induced hypotension. Am. J. Nephrol., 1990, 10, s. 269-275.
26. Malay, M. B., Ashton, R. C., Jr., Landry, D. W., Townsend, R. N.: Low-dose vasopressin in the treatment of vasodilatory septic shock. J. Trauma, 1999, 47, s. 699-703.
27. Morales, D., Madigan, J., Cullinane, S. et al.: Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation, 1999, 100, s. 226-229.
28. Morales, D. L., Gregg, D., Helman, D. N. et al.: Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann. Thorac. Surg., 2000, 69, s. 102-106.
29. Patel, B. M., Chittock, D. R., Russell, J. A., Walley, K. R.: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology, 2002, 96, s. 576-582.
30. Rosenzweig, E. B., Star, T. J., Chen, J. M.: Intravenous argininevasopresin in children with vasodilatory shock after cardiac surgery. Circulation, 1999, 100 (Suppl. 2), s. 182-186.
31. Tsuneyoshi, I., Yamada, H., Kakihana, Y. et al.: Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit. Care Med., 2001, 29, s. 487-493.
32. Yoshioka, T., Sugimoto, H., Uenishi, M. et al.: Prolonged hemodynamic maintenance by the combined administration of vasopressin and epinephrine in brain death: a clinical study. Neurosurgery, 1986, 18, s. 565-567.
33. Jolley, D. H., De Keulenaer, B. L., Potter, A., Stephens, D. P.: Terlipressin infusion in catecholamine-resistant shock. Anaesth. Intensive Care, 2003, 31, s. 560-564.
34. Morelli, A., Rocco, M., Conti, G. et al.: Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med., 2003 (v tisku).
35. O'Brien, A., Clapp, L., Singer, M.: Terlipressin for norepinephrine-resistant septic shock. Lancet, 2002, 359, s. 1209-1210.
36. Lamarre, P., Perreault, B., Lesur, O.: Vasopressin and blood pressure support for pancreatitis-induced systemic inflammatory response syndrome with circulatory shock. Pharmacotherapy, 2001, 21, s. 506-508.
37. Dunser, M. W., Wenzel, V., Mayr, A. J., Hasibeder, W. R.: Management of vasodilatory shock: defining the role of arginine vasopressin. Drugs, 2003, 63, s. 237-256.
38. Dunser, M. W., Mayr, A. J., Tur, A. et al.: Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors. Crit. Care Med., 2003, 31, s. 1394-1398.
39. Dubois, M. J., De Backer, D., Creteur, J. et al.: Effect of vasopressin on sublingual microcirculation in a patient with distributive shock. Intensive Care Med., 2003, 29, s. 1020-1023.
40. Klinzing, S., Simon, M., Reinhart, K. et al.: High-dose vasopressin is not superior to norepinephrine in septic shock. Crit. Care Med., 2003, 31, s. 2646-2650.
41. van Haren, F. M., Rozendaal, F. W., van der Hoeven, J. G.: The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest, 2003, 124, s. 2256-2260.